UnitedHealth Group’s $3.29 billion takeover of Amedisys will undergo an in-depth antitrust review by the Department of Justice, according to a filing from Amedisys. The home-health company disclosed in a regulatory filing that it received a so-called second request seeking additional information on the deal from the antitrust agency on Aug. 4, Bloomberg reports. Read more.
Related Posts
Shopping for Space, Health Systems Make Over Malls
Nationwide, 32 enclosed malls house health care services in at least part of their footprint.
April 27, 2022
As Politics Infects Public Health, Private Companies Profit
For some counties and cities that share a public health agency with other local governments, differences over mask mandates, business restrictions, and other covid preventive measures have strained those partnerships.
February 17, 2022
Hospital Coalition Urges FTC to Abandon Unprecedented Challenge to State-Approved Merger
The groups oppose the FTC's interference in Louisiana Children’s Medical Center’s state-approved merger with HCA Healthcare.
May 19, 2023
Hospitals Want More Time to Review Proposed Premerger Notification Rule
The American Hospital Association and the Federation of American Hospitals joined 20 other organizations to urge the Federal Trade Commission to extend by 60 days the public comment period for its proposed changes to the premerger notification form and rules.
July 19, 2023